Clinical Trials Logo

Puncture clinical trials

View clinical trials related to Puncture.

Filter by:
  • None
  • Page 1

NCT ID: NCT05982366 Completed - Clinical trials for Coronary Artery Disease

Feasibility and Safety of the Routine Distal Transradial Approach

ANTARES
Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The distal transradial approach (dTRA) via the anatomical snuffbox is hypothesized to be more beneficial than the conventional transradial access (cTRA) in patients undergoing coronary procedures. This prospective single-center randomized trial was designed to investigate the safety, efficacy, and various ultrasound parameters of dTRA.

NCT ID: NCT05928663 Completed - Orthopedic Disorder Clinical Trials

The Effect of Using Double Gloves on Perforation in Orthopedic Surgery

Start date: November 30, 2021
Phase: N/A
Study type: Interventional

Aim: This study aimed to investigate the effect of using double gloves on perforation in orthopedic surgery. Materials and Method: The randomized controlled experimental study was conducted between 30.11.2021 and 31.03.2022 in the Orthopedics and Traumatology operating room of a university hospital in western Turkey. The gloves used in the surgery were randomly divided into two groups (intervention: double glove group = 780 gloves, control: single glove group = 390). The presence of holes was checked by performing a water tightness test with the EN455-1 method on all gloves collected after the surgery by the researcher. Data were evaluated with descriptive statistics, Chi-square Test, Fisher Exact Test, and linear model regression analysis (GLM for the Binomial Family Regression). Statistical significance was accepted as 0.05.

NCT ID: NCT05822804 Not yet recruiting - Hemostasis Clinical Trials

Safety and Efficacy of the Vascular Closure Device (Tonbridge) in Hemostasis Treatment of Femoral Artery Puncture

Start date: April 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to verify the safety and efficacy of the Vascular Closure Device (Tonbridge) in hemostasis treatment for femoral artery puncture.

NCT ID: NCT04080700 Completed - Clinical trials for Coronary Artery Disease

Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)

Start date: September 9, 2019
Phase:
Study type: Observational [Patient Registry]

The left distal radial approach (DRA) has been introduced as a feasible and safe alternative route of the radial artery. However, there is still lack of evidence for DRA regarding the feasibility, safety, effective time for hemostasis and hemostasis method. This prospective multicenter registry aimed to investigate the safety and efficacy of DRA for CAG and PCI.

NCT ID: NCT03709797 Recruiting - Clinical trials for Spinal Cord Injuries

Effectiveness of Dry Needling as a Treatment of Shoulder Myofascial Pain Syndrome in Spinal Cord Injury Patients

Start date: November 9, 2018
Phase: N/A
Study type: Interventional

Shoulder pain in people with spinal cord injury is one of the most prevalent in acute and chronic patients because of weakness in shoulder periarticular muscles, and also because of overuse of these part of the body in assistive devices. This study aims to evidence if dry needling (a physiotherapy technique) is also useful in patients with spinal cord injury, and how long it could hold out without or less pain.

NCT ID: NCT03444051 Completed - Pancreatic Tumor Clinical Trials

Comparison of Two Endoscopic Biopsic Needles for Pancreatic Tumors

Mousquetaires
Start date: March 1, 2017
Phase: N/A
Study type: Observational

This observational study compared quality of histological sampling of pancreatic EUS-FNB with the 20-gauge Procore® and 22-gauge Acquire® needles. In total, 68 patients were recruited. Histological diagnosis was achieved and a histological core biopsy was obtained in 82% of patients (28/34) in the 20-gauge Procore® group and 97% of patients (33/34) in the 22-gauge Acquire® group (P=0.1). Core biopsy specimens obtained were significantly longer with the 22-gauge Acquire® needle with a mean cumulative length of tissue core biopsies per needle pass of 4,33±3,46mm vs. 7,9±4,35mm for the 20-gauge Procore® (P<0,01). Reproducibility of this simple histological criterion was validated in intra and inter-observer.

NCT ID: NCT02954029 Recruiting - Clinical trials for Coronary Artery Disease

Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures

Start date: April 2016
Phase: Phase 4
Study type: Interventional

Arterial access is the key step during the endovascular treatment of cardiovascular diseases. This study was designed to confirm the safety and efficacy of the hemostasis pad using chitosan in patients undergoing percutaneous procedures with arterial approach. Two cohorts will be included in this study: transradial and transfemoral cohort. Among the transfemoral cohort, the safety and efficacy of the ezClot pad will be compared with the BloodSTOP® pad (LifeScience PLUS, Palo Alto, CA, USA). The BloodSTOP® pad is an etherized and oxidized regenerated cellulose matrix that achieves hemostasis by activating the intrinsic coagulation pathway. The hypothesis will be tested among the transradial cohort that the combined use of a hemostasis pad and a compression device is superior to that of a compression device only in terms of hemostasis in patients who underwent tranradial coronary procedures.